3rd Feb 2021 4:36 pm |
RNS |
MaxCyte Announces £40 million Subscription |
3rd Feb 2021 4:35 pm |
RNS |
Appointment of Joint Corporate Broker |
21st Jan 2021 2:49 pm |
RNS |
Increase to Block Listing |
20th Jan 2021 7:00 am |
RNS |
Trading Update |
11th Jan 2021 7:00 am |
RNS |
Myeloid Therapeutics Clinical & Commercial License |
23rd Dec 2020 7:00 am |
RNS |
Trading Update |
9th Nov 2020 1:00 pm |
RNS |
CARMA Cell Therapies at SITC 2020 |
9th Nov 2020 7:00 am |
RNS |
Presentations at Upcoming Virtual IR Conferences |
2nd Nov 2020 3:52 pm |
RNS |
Result of AGM |
22nd Oct 2020 6:22 pm |
RNS |
Disclosure of Remuneration for Non-Audit Services |
14th Oct 2020 7:00 am |
RNS |
Notification of AGM and Audit Declaration |
13th Oct 2020 7:00 am |
RNS |
MaxCyte announces leadership appointments |
1st Oct 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
21st Sep 2020 7:00 am |
RNS |
Results for the Six Months ended 30 June 2020 |
10th Sep 2020 1:42 pm |
RNS |
Grant of options |
10th Sep 2020 7:00 am |
RNS |
HC Wainright & Co Virtual Conference Presentation |
9th Sep 2020 7:00 am |
RNS |
Appointment of Amanda L. Murphy as CFO |
2nd Sep 2020 2:57 pm |
RNS |
Holding(s) in Company |
2nd Sep 2020 7:00 am |
RNS |
Notice of Half Year Results |
18th Aug 2020 7:00 am |
RNS |
Expansion of CARMA’s Phase I Trial of MCY-M11 |
14th Aug 2020 7:00 am |
RNS |
Holding(s) in Company |
16th Jul 2020 6:04 pm |
RNS |
Director Dealings and Issue of Equity |
15th Jul 2020 7:00 am |
RNS |
Trading Update |
8th Jul 2020 7:00 am |
RNS |
APEIRON Biologics Clinical and Commercial License |
1st Jul 2020 7:00 am |
RNS |
Block Listing Return & TVR |
2nd Jun 2020 5:54 pm |
RNS |
Holding(s) in Company |
28th May 2020 3:34 pm |
RNS |
Holding(s) in Company |
26th May 2020 5:49 pm |
RNS |
Holding(s) in Company |
26th May 2020 4:22 pm |
RNS |
Holding(s) in Company |
26th May 2020 3:45 pm |
RNS |
Holdings in Company |
21st May 2020 1:50 pm |
RNS |
Result of Special Meeting and Issue of Equity |
14th May 2020 7:00 am |
RNS |
Poster Presentation on MCY-M11 at ASCO 2020 |
7th May 2020 7:00 am |
RNS |
License Agreement with Caribou Biosciences |
1st May 2020 7:00 am |
RNS |
Result of Offering |
30th Apr 2020 5:39 pm |
RNS |
Proposed Offering to raise up to £25.1 million |
21st Apr 2020 7:00 am |
RNS |
Final Results for Year Ended 31 December 2019 |
9th Apr 2020 7:00 am |
RNS |
Business Update Related to COVID-19 Pandemic |
24th Mar 2020 7:00 am |
RNS |
License Agreement with Allogene Therapeutics |
21st Feb 2020 7:00 am |
RNS |
Consolidation of Trading Lines |
20th Feb 2020 6:18 pm |
RNS |
AIM Block Admission Return / Total Voting Rights |